WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INMB

Based on 1 analyst offering 12 month price targets for Inmune Bio Inc

Min Forecast
$9.00+520.69%
Avg Forecast
$9.00+520.69%
Max Forecast
$9.00+520.69%

Should I buy or sell INMB stock?

Based on 1 analyst offering ratings for Inmune Bio Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INMB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates INMB as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their INMB stock forecasts and price targets.

INMB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-11Find Out Why

1 of 1

Forecast return on equity

Is INMB forecast to generate an efficient return?

Company
95.35%
Industry
94.37%
Market
175.99%
INMB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INMB forecast to generate an efficient return on assets?

Company
72.47%
Industry
27.62%
INMB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INMB earnings per share forecast

What is INMB's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.76
Avg 2 year Forecast
-$1.11
Avg 3 year Forecast
-$0.68

INMB revenue forecast

What is INMB's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$2.0M
Avg 3 year Forecast
$25.6M

INMB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INMB$1.45$9.00+520.69%Strong Buy
APLM$17.50N/AN/A
GRCE$2.38$8.00+236.13%Strong Buy
CRVO$4.24$22.00+418.87%Strong Buy
GNTA$1.68N/AN/A
View Top Biotech Stocks

Inmune Bio Stock Forecast FAQ

Is Inmune Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INMB) stock is to Strong Buy INMB stock.

Out of 1 analyst, 1 (100%) are recommending INMB as a Strong Buy, 0 (0%) are recommending INMB as a Buy, 0 (0%) are recommending INMB as a Hold, 0 (0%) are recommending INMB as a Sell, and 0 (0%) are recommending INMB as a Strong Sell.

If you're new to stock investing, here's how to buy Inmune Bio stock.

What is INMB's earnings growth forecast for 2026-2028?

(NASDAQ: INMB) Inmune Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.05%.

Inmune Bio's earnings in 2026 is -$41,601,000.On average, 6 Wall Street analysts forecast INMB's earnings for 2026 to be -$20,202,138, with the lowest INMB earnings forecast at -$27,356,230, and the highest INMB earnings forecast at -$12,282,389. On average, 5 Wall Street analysts forecast INMB's earnings for 2027 to be -$29,557,490, with the lowest INMB earnings forecast at -$28,398,373, and the highest INMB earnings forecast at -$30,426,828.

In 2028, INMB is forecast to generate -$18,168,365 in earnings, with the lowest earnings forecast at -$17,455,880 and the highest earnings forecast at -$18,702,729.

What is INMB's revenue growth forecast for 2026-2028?

(NASDAQ: INMB) Inmune Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Inmune Bio's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast INMB's revenue for 2026 to be $0, with the lowest INMB revenue forecast at $0, and the highest INMB revenue forecast at $0. On average, 5 Wall Street analysts forecast INMB's revenue for 2027 to be $52,878,078, with the lowest INMB revenue forecast at $0, and the highest INMB revenue forecast at $108,866,632.

In 2028, INMB is forecast to generate $679,572,365 in revenue, with the lowest revenue forecast at $474,174,662 and the highest revenue forecast at $891,058,092.

What is INMB's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INMB) forecast ROA is 72.47%, which is higher than the forecast US Biotechnology industry average of 27.62%.

What is INMB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INMB price target, the average INMB price target is $9.00, with the highest INMB stock price forecast at $9.00 and the lowest INMB stock price forecast at $9.00.

The Wall Street analyst predicted that Inmune Bio's share price could reach $9.00 by Mar 11, 2027. The average Inmune Bio stock price prediction forecasts a potential upside of 520.69% from the current INMB share price of $1.45.

What is INMB's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INMB) Inmune Bio's current Earnings Per Share (EPS) is -$1.67. On average, analysts forecast that INMB's EPS will be -$0.76 for 2026, with the lowest EPS forecast at -$1.03, and the highest EPS forecast at -$0.46. On average, analysts forecast that INMB's EPS will be -$1.11 for 2027, with the lowest EPS forecast at -$1.07, and the highest EPS forecast at -$1.14. In 2028, INMB's EPS is forecast to hit -$0.68 (min: -$0.66, max: -$0.70).

What is INMB's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INMB) forecast ROE is 95.35%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.